Proprietary Vialon biomaterial softens up to 70% in the vein, enabling longer dwell times and reducing the chance of mechanical phlebitis.
Instaflash needle technology provides quick blood visualization that may help improve insertion success and therefore reduce insertion attempts.
Built-in stabilization platform reduces dislodgement by 84% and complies with the Infusion Therapy Standards of Practice and CDC guidelines for catheter stabilization.
Pre-attached extension set is shown to significantly reduce blood exposure during insertion compared to an open system and aligns with INS guidelines.
